Inui Y | Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
スポンサーリンク
概要
- 同名の論文著者
- Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicineの論文著者
関連著者
-
Inui Y
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Inoue Yuko
大阪大学 医学系研究科消化器内科
-
Imai Yasuharu
Department Of Gastroenterology Ikeda Municipal Hospital
-
Imai Yasuharu
大阪大学 医学系研究科消化器内科
-
Kawata S
Second Department Of Internal Medicine Yamagata University School Of Medicine
-
Kiso Shinichi
Second Department Of Internal Medicine Osaka University Medical School
-
Kubota Shinji
大阪大学 医学系研究科消化器内科学
-
Kawata Sumio
Department Of Gastroenterology Faculty Of Medicine Yamagata University
-
Kihara Shinji
大阪大学 医学系研究科消化器内科学
-
Hiramatsu Naoki
大阪大学 医学系研究科消化器内科
著作論文
- Gastrointestinal Stromal Tumors Treated by Laparoscopic Surgery : Report of Three Cases
- Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5-Fluorouracil
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Juvenile hepatocellular carcinoma with congestive liver cirrhosis
- Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
- Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial